Trial intelligence / Profile preview

Oliceridine vs Sufentanil for Anesthesia Induction in Gynecological Laparoscopic Surgery

NCT07372209Completed

Sponsor
Tangshan Maternal and Child Health Hospital
Start
Oct 2025
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Trial of oliceridine in general anesthesia (2 arms), sponsored by Tangshan Maternal and Child Health Hospital. Primary endpoints: Blood Pressure and Heart Rate. Started Oct 2025; status: completed.

02

Drugs

oliceridine
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT07372209.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07372209.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call